10980nam 2200565 450 991050298580332120220928121112.0981-16-4047-5(CKB)4100000012025715(MiAaPQ)EBC6724613(Au-PeEL)EBL6724613(OCoLC)1268113376(PPN)258057734(EXLCZ)99410000001202571520220616d2021 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierGranulomatous diseases in otorhinolaryngology, head and neck /Sanjana Vijay Nemade, Kiran Jaywant ShindeSingapore :Springer,[2021]©20211 online resource (329 pages)981-16-4046-7 Intro -- Preface -- Acknowledgement -- Introduction -- Clinical Features of Granulomatous Diseases -- Diagnosis of Granulomatous Diseases -- Treatment of Granulomatous Diseases -- Contents -- About the Authors -- Part I: Autoimmune Granulomatous Diseases -- 1: Granulomatosis with Polyangiitis-GPA (Wegener's Granulomatosis) -- 1.1 Background -- 1.2 Epidemiology -- 1.3 Etiopathogenesis -- 1.4 Clinical Features -- 1.4.1 Sinonasal Features -- 1.4.2 Oropharyngeal Features -- 1.4.3 Laryngotracheal Involvement -- 1.4.4 Otological Features -- 1.4.4.1 Hearing Loss -- 1.4.4.2 Vertigo or Disequilibrium -- 1.4.4.3 Facial Paralysis -- 1.4.5 Salivary Gland Involvement -- 1.4.6 Other System Involvement -- 1.5 Diagnosis -- 1.5.1 Classification Criteria for GPA -- 1.5.1.1 Histopathology -- 1.5.1.2 Serology -- 1.5.1.3 Endoscopy -- 1.5.1.4 Imaging: -- 1.5.1.5 Pulmonary Function Tests: -- 1.6 Treatment -- 1.6.1 Maintainance of Remission -- 1.7 Essential Features -- References -- 2: Churg-Strauss Syndrome -- 2.1 Background -- 2.2 Epidemiology -- 2.3 Etiopathogenesis -- 2.4 Clinical Features -- 2.5 Diagnosis -- 2.5.1 The Six Criteria -- 2.5.2 Endoscopy -- 2.5.3 The Birmingham Vasculitis Activity Score (BVAS) -- 2.5.4 Blood Cells and Biomarkers -- 2.5.5 Imaging -- 2.5.6 Histopathology -- 2.5.7 Other Tests -- 2.6 Treatment -- 2.6.1 Oral Corticosteroids and Immunosuppressants -- 2.6.2 Supportive Therapy -- 2.7 Essential Features -- References -- 3: Behcet's Disease -- 3.1 Overview -- 3.2 Epidemiology -- 3.3 Etiopathogenesis -- 3.4 Clinical Features -- 3.4.1 Other System Involvement -- 3.5 Diagnosis -- 3.5.1 Histopathology -- 3.5.2 Other Tests -- 3.6 Treatment -- 3.6.1 Pharmacotherapy -- 3.6.2 Surgery -- 3.7 Essential Features -- References -- Part II: Infective Granulomatous Diseases -- 4: Tuberculosis -- 4.1 Background.4.2 Epidemiology -- 4.3 Etiopathogenesis -- 4.3.1 There are Two Major Patterns of Disease with TB -- 4.4 Clinical Features -- 4.4.1 Laryngeal TB -- 4.4.2 TB of Cervical Lymph Nodes -- 4.4.3 Aural TB -- 4.4.4 Nasal TB -- 4.4.5 TB in the Oral Cavity and Oropharynx -- 4.5 Diagnosis -- 4.5.1 Microscopy and Culture -- 4.5.2 Histopathology -- 4.5.3 Imaging -- 4.5.4 The Mantoux Tuberculin Skin Test -- 4.5.5 Serology -- 4.5.6 Molecular Assay -- 4.5.6.1 Nucleic Acid Amplification Tests -- 4.5.7 Latent TB -- 4.5.8 New Cases of Active TB -- 4.5.9 Previously Treated Cases -- 4.5.9.1 The Standard Re-treatment Regimen Consists of -- 4.5.10 Treatment of Drug-Resistant Tuberculosis -- 4.5.10.1 Medication Administration -- 4.5.10.2 Duration of Treatment -- 4.5.10.3 Surgical Management -- 4.5.10.4 Vaccination -- 4.6 Essential Features -- References -- 5: Syphilis -- 5.1 Background -- 5.2 Epidemiology -- 5.3 Etiopathogenesis -- 5.3.1 Primary Syphilis -- 5.3.2 Secondary Syphilis -- 5.3.3 Tertiary Syphilis (Gummatous Syphilis) -- 5.3.4 Congenital Syphilis -- 5.4 Clinical Features -- 5.4.1 Ear Manifestations -- 5.4.2 The Oral Cavity and Oropharyngeal Manifestations -- 5.4.3 The Larynx and Hypopharyngeal Manifestations -- 5.4.4 The Nose and Nasopharyngeal Manifestations -- 5.5 Diagnosis -- 5.5.1 Clinical Diagnosis is Aided by the Following Diagnostic Tests [18] -- 5.5.2 Darkfield Examination -- 5.5.3 Serologic Tests -- 5.5.4 Histopathology -- 5.5.5 Imaging -- 5.6 Treatment -- 5.6.1 Primary, Secondary, and Early Tertiary Disease -- 5.6.1.1 First-Line Treatment -- 5.6.2 Late Tertiary Disease -- 5.6.2.1 First-Line Treatment -- 5.6.2.2 Alternate Treatment -- 5.6.3 Surgical Management -- 5.7 Essential Features -- References -- 6: Leprosy -- 6.1 Background -- 6.2 Epidemiology -- 6.3 Etiopathogenesis.6.4 Clinical Features -- 6.5 ENT Manifestations -- 6.6 Diagnosis -- 6.6.1 Histopathology -- 6.6.2 Serology -- 6.6.3 Molecular Assay -- 6.6.4 Other Tests -- 6.6.5 Interpretation -- 6.6.6 Imaging -- 6.7 Treatment -- 6.7.1 WHO Recommendations for Treatment of Leprosy [14] -- 6.7.2 United States Recommendations for Treatment of Leprosy [14] -- 6.7.2.1 Surgical Management -- 6.8 Essential features -- References -- 7: Actinomycosis -- 7.1 Background -- 7.2 Epidemiology -- 7.3 Etiopathogenesis -- 7.4 Clinical Features -- 7.4.1 Other Features -- 7.5 Diagnosis -- 7.5.1 Cytology -- 7.5.2 Culture -- 7.5.3 Histopathology -- 7.5.4 Imaging -- 7.5.5 Serology -- 7.5.6 Molecular Assay -- 7.6 Treatment -- 7.7 Essential Features -- References -- 8: Rhinoscleroma -- 8.1 Background -- 8.2 Epidemiology -- 8.3 Etiopathogenesis -- 8.4 Clinical Features -- 8.5 Complications -- 8.6 Diagnosis -- 8.6.1 Endoscopy -- 8.6.2 Microscopy and Culture -- 8.6.3 Histopathology -- 8.6.3.1 The Histologic Findings Correspond to the Three Clinical Stages [7, 8] -- 8.6.4 Imaging -- 8.7 Treatment -- 8.7.1 Surgical Management -- 8.8 Essential Features -- References -- 9: Cat Scratch Disease -- 9.1 Background -- 9.2 Epidemiology -- 9.3 Etiopathogenesis -- 9.4 Clinical Features -- 9.5 Diagnosis -- 9.5.1 Imaging -- 9.5.2 Fine Needle Aspiration Cytology -- 9.5.3 Lymph Node Biopsy -- 9.5.4 Serology -- 9.5.5 Molecular Assay -- 9.6 Treatment -- 9.7 Essential Features -- References -- 10: Lyme Disease -- 10.1 Background -- 10.2 Epidemiology -- 10.3 Etiopathogenesis -- 10.4 Clinical Features -- 10.4.1 Stages of Disease -- 10.4.1.1 Early Localized Infection -- 10.4.1.2 Early Disseminated Infection -- Nervous System Involvement (Neuroborreliosis) -- Cardiovascular Involvement -- 10.4.1.3 Late Disseminated Infection -- 10.5 Diagnosis.10.5.1 Microscopy and Culture -- 10.5.2 Histopathology -- 10.5.3 Immunohistochemistry -- 10.5.4 Serology -- 10.5.5 Molecular Assay -- 10.5.6 Imaging -- 10.5.7 Other Tests -- 10.6 Treatment -- 10.7 Essential Features -- References -- 11: Tularemia -- 11.1 Background -- 11.2 Epidemiology -- 11.3 Etiopathogenesis -- 11.4 Clinical Features -- 11.5 Diagnosis -- 11.5.1 Culture -- 11.5.2 Serology -- 11.5.3 Molecular Assay -- 11.5.4 Histopathology -- 11.5.5 Imaging -- 11.6 Treatment -- 11.6.1 First-Line Therapy -- 11.6.2 Second-Line Therapy -- 11.7 Essential Features -- References -- 12: Aspergillosis -- 12.1 Background -- 12.2 Epidemiology -- 12.3 Etiopathogenesis -- 12.4 Risk Factors -- 12.5 Clinical Features -- 12.5.1 Saprophytic Aspergillosis -- 12.5.1.1 Aspergilloma (Fungal Ball) -- 12.5.1.2 Chronic Pulmonary Aspergillosis (CPA) -- 12.5.2 Allergic Aspergillosis -- 12.5.3 Invasive Aspergillosis -- 12.6 Diagnosis -- 12.6.1 Microscopy and Culture -- 12.6.2 Histopathology -- 12.6.3 Immunohistochemistry for Fungal Identification -- 12.6.4 Imaging -- 12.6.5 Serology -- 12.6.6 Molecular Assay -- 12.6.7 Other Tests -- 12.7 Treatment -- 12.7.1 Invasive Aspergillosis (IA) -- 12.7.2 Noninvasive Aspergillosis -- 12.7.3 Glucocorticoids -- 12.7.4 Antifungal Drugs -- 12.7.5 Anti-IgE Therapy -- 12.7.6 Anti-Th2 Therapies -- 12.7.7 Surgical Management -- 12.8 Essential Features -- References -- 13: Mucormycosis -- 13.1 Background -- 13.2 Epidemiology -- 13.3 Etiopathogenesis -- 13.4 Classification -- 13.4.1 Predisposing Factors -- 13.5 Clinical Features -- 13.6 Diagnosis -- 13.6.1 Microscopy and Culture -- 13.6.2 Culture -- 13.6.3 Histopathology -- 13.6.4 Serology -- 13.6.5 Molecular Assay -- 13.6.6 Imaging -- 13.7 Treatment -- 13.7.1 First-Line Monotherapy.13.7.2 Dose of AmB (amphotericin B deoxycholate) -- 13.7.3 Salvage Therapy -- 13.7.4 Surgical Management -- 13.7.5 Post Covid-19 Mucormycosis (From Frying Pan to Fire) -- 13.8 Essential Features -- References -- 14: Rhinosporidiosis -- 14.1 Background -- 14.2 Epidemiology -- 14.3 Etiopathogenesis -- 14.4 Clinical Features -- 14.4.1 Symptoms -- 14.4.2 Signs of Nasal Rhinospridiosis Mass -- 14.5 Diagnosis -- 14.5.1 Cytology and Histopathology -- 14.5.2 Serology -- 14.5.3 Imaging -- 14.6 Treatment -- 14.7 Essential Features -- References -- 15: Candidiasis -- 15.1 Background -- 15.2 Epidemiology -- 15.2.1 Global Emergence of Candida Auris -- 15.2.2 3 Major Concerns About It Are -- 15.3 Etiopathogenesis -- 15.3.1 Virulence Properties of Candida Species -- 15.4 Clinical Features -- 15.4.1 Primary Candidiasis -- 15.4.2 Secondary Candidiasis -- 15.5 Candida-Associated Lesions -- 15.5.1 Denture stomatitis -- 15.6 Diagnosis -- 15.6.1 Microscopy and Culture -- 15.6.2 Histopathology -- 15.6.3 Candida Species Identification -- 15.6.4 Endoscopy -- 15.6.5 Imaging -- 15.6.6 Serology -- 15.6.7 Molecular Assay -- 15.6.8 Blood Tests -- 15.7 Treatment -- 15.8 Essential Features -- References -- 16: Histoplasmosis -- 16.1 Background -- 16.2 Epidemiology -- 16.3 Etiopathogenesis -- 16.4 Clinical Features -- 16.5 Diagnosis -- 16.5.1 Microscopy -- 16.5.2 Culture -- 16.5.3 Histopathology -- 16.5.4 Serology -- 16.5.5 Imaging -- 16.6 Treatment -- 16.7 Essential Features -- References -- 17: Cryptococcosis -- 17.1 Background -- 17.2 Epidemiology -- 17.3 Etiopathogenesis -- 17.4 Clinical Features -- 17.4.1 CNS Manifestations -- 17.4.2 Pulmonary Cryptococcosis -- 17.4.3 Cutaneous and Mucocutaneous Cryptococcosis -- 17.4.4 Other Manifestations -- 17.5 Diagnosis -- 17.5.1 Microscopy and Culture -- 17.5.2 Histopathology.17.5.3 Differentiation Between C. neoformans and C. gattii.GranulomaOtolaryngologyDiagnosisTumorsthubOtorrinolaringologiathubLlibres electrònicsthubGranuloma.OtolaryngologyDiagnosis.TumorsOtorrinolaringologia616.0473Nemade Sanjana Vijay1069144Shinde Kiran JaywantMiAaPQMiAaPQMiAaPQBOOK9910502985803321Granulomatous Diseases in Otorhinolaryngology, Head and Neck2554683UNINA00969nam0 22002531i 450 UON0042272120231205104833.30220130416f1947 |0itac50 bafreFR|||| 1||||Pages CatholiquesHenry De Montherlantrecuillies et presentées par Marya Kasterskaavec une lettre de l'auteurParisPlonc1947209 p.18 cm.FRParisUONL002984840.9Letteratura francese. 1900-21MONTHERLANTHenry deUONV114617201912GallimardUONV246610650ITSOL20240220RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00422721SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI Francese VI A MON 10 SI MR 21102 5 10 BuonoPages Catholiques1334516UNIOR05554nam 22006972 450 991082609140332120180511142958.01-86814-764-9(CKB)3710000000442536(EBL)2092960(SSID)ssj0001539111(PQKBManifestationID)11833794(PQKBTitleCode)TC0001539111(PQKBWorkID)11529184(PQKB)10316986(OCoLC)1019657823(MdBmJHUP)muse58005(UkCbUP)CR9781868147649(Au-PeEL)EBL3545163(CaPaEBR)ebr11074340(CaONFJC)MIL958645(OCoLC)951038525(Au-PeEL)EBL2092960(OCoLC)914150792(MiAaPQ)EBC3545163(EXLCZ)99371000000044253620180223d2014|||| uy| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierNew South African review 4 a fragile democracy - twenty years on /edited by Gilbert M. Khadiagala [and others][electronic resource]Johannesburg :Wits University Press,2014.1 online resource (378 pages) digital, PDF file(s)New South African ReviewTitle from publisher's bibliographic system (viewed on 09 May 2018).1-86814-797-5 1-86814-763-0 Includes bibliographical references and index.Introduction. South Africa's fragile democracy: twenty years on / Devan Pillay and Roger Southall -- pt. 1. Ecology, economy and labour. Introduction / Devan Pillay -- The South African labour market after eighteen years : It's class struggle, stupid! / Nicolas Pons-Vignon and Miriam Di Paola -- The state of organised labour : still living like there's no tomorrow / Ian Macun --Citizen Wal-Mart? South African food retailing and selling development / Bridget Kenny -- Transcending South Africa's oil dependency / Jeremy Wakeford -- The politics of electricity generation in South Africa / Keith Gottschalk -- pt. 2. Power, politics and participation. -- Introduction / Prishani Naidoo -- Platinum, poverty and princes in post-apartheid South Africa : new laws, old repertoires / Aninka Claassens and Boitumelo Matlala -- amaDiba moment : how civil courage confronted sttate and corporate collusion / John G.I. Clarke -- Secrecy and power in South Africa / Dale T. McKinley -- The contemporary relevance of Black Consciousness in South Africa / Xolela Mangcu -- Death and the modern black lesbian / Zethu Matebeni -- pt. 3. Public policy and social practice. Introduction / Roger Southall -- Why does Zimbabwe's school system out-perform South Africa's? / Martin Prew -- Higher education in 2013: at many crossroads / Ahmed Bawa -- Democracy without economic emancipation : household relations and policy in South Africa / Sarah Mosoetsa -- Prisons, the law and overcrowding / Clare Ballard -- pt. 4. South Africa at large. Introduction / Gilbert M. Khadiagala -- South Africa in Africa : groping for leadership and muddling through / Gilbert M. Khadiagala -- South Africa and Israel : from alliance to estrangement / Ran Greenstein -- South Africa's economic ties with north-east Asia / Scarlett Cornelissen -- Regional parastatals within South Africa's system of accumulation / Justin van der Merwe -- The leadership challenge in Southern Africa / Mopeli L. Moshoeshoe.The death of Nelson Mandela on 5 December 2013 was in a sense a wake-up call for South Africans, and a time to reflect on what has been achieved since 'those magnificent days in late April 1994' (as the editors of this volume put it) 'when South Africans of all colours voted for the first time in a democratic election'. In a time of recall and reflection it is important to take account, not only of the dramatic events that grip the headlines, but also of other signposts that indicate the shape and characteristics of a society. The New South African Review looks, every year, at some of these signposts, and the essays in this fourth volume of the series again examine and analyse a broad spectrum of issues affecting the country. They tackle topics as diverse as the state of organised labour; food retailing; electricity generation; access to information; civil courage; the school system; and - looking outside the country to its place in the world - South Africa's relationships with north-east Asia, with Israel and with its neighbours in the southern African region. Taken together, these essays give a multidimensional perspective on South Africa's democracy as it turns twenty, and will be of interest to general readers while being particularly useful to students and researchers.New South African ReviewEconomic developmentSouth AfricaDemocracySouth AfricaSouth AfricaEconomic conditions21st centurySouth AfricaEconomic policySouth AfricaSocial conditions1994-South AfricaSocial policySouth AfricaPolitics and government21st centuryEconomic developmentDemocracy338.968Ballard Clare1675609Khadiagala Gilbert M.UkCbUPUkCbUPBOOK9910826091403321New South African review 44041231UNINA